Mainz Biomed Statistics

Total Valuation

Mainz Biomed has a market cap or net worth of $5.32 million. The enterprise value is $5.82 million.

Market Cap	5.32M
Enterprise Value	5.82M

Important Dates

The next estimated earnings date is Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Mainz Biomed has 21.89 million shares outstanding. The number of shares has increased by 14.73% in one year.

Shares Outstanding	21.89M
Shares Change (YoY)	+14.73%
Shares Change (QoQ)	+19.54%
Owned by Insiders (%)	15.98%
Owned by Institutions (%)	6.13%
Float	18.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.53
Forward PS	2.72
PB Ratio	1.63
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 2.28.

Current Ratio	0.97
Quick Ratio	0.80
Debt / Equity	2.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.62

Financial Efficiency

Return on equity (ROE) is -303.20% and return on invested capital (ROIC) is -118.97%.

Return on Equity (ROE)	-303.20%
Return on Assets (ROA)	-93.42%
Return on Capital (ROIC)	-118.97%
Revenue Per Employee	$12,612
Profits Per Employee	-$370,362
Employee Count	71
Asset Turnover	0.05
Inventory Turnover	0.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.17% in the last 52 weeks. The beta is 0.12, so Mainz Biomed's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-92.17%
50-Day Moving Average	0.35
200-Day Moving Average	0.76
Relative Strength Index (RSI)	35.25
Average Volume (20 Days)	2,164,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mainz Biomed had revenue of $895,479 and -$26.30 million in losses. Loss per share was -$1.62.

Revenue	895,479
Gross Profit	509,659
Operating Income	-26.64M
Pretax Income	-26.30M
Net Income	-26.30M
EBITDA	-26.07M
EBIT	-26.64M
Loss Per Share	-$1.62

Full Income Statement

Balance Sheet

The company has $7.07 million in cash and $7.42 million in debt, giving a net cash position of -$349,855 or -$0.02 per share.

Cash & Cash Equivalents	7.07M
Total Debt	7.42M
Net Cash	-349,855
Net Cash Per Share	-$0.02
Equity (Book Value)	3.25M
Book Value Per Share	0.15
Working Capital	-257,148

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.94 million and capital expenditures -$1.20 million, giving a free cash flow of -$23.14 million.

Operating Cash Flow	-21.94M
Capital Expenditures	-1.20M
Free Cash Flow	-23.14M
FCF Per Share	-$1.06

Full Cash Flow Statement

Margins

Gross Margin	56.91%
Operating Margin	-2,975.47%
Pretax Margin	-2,936.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,662.00%

Dividends & Yields

Mainz Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.73%
Shareholder Yield	-14.73%
Earnings Yield	-480.77%
FCF Yield	-423.03%

Analyst Forecast

The average price target for Mainz Biomed is $3.00, which is 1,134.57% higher than the current price. The consensus rating is "Buy".

Price Target	$3.00
Price Target Difference	1,134.57%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	159.62%
EPS Growth Forecast (5Y)	-52.11%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mainz Biomed has an Altman Z-Score of -8.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.75
Piotroski F-Score	3